ZEAL Network Full Year 2024 Earnings: Beats Expectations
Full Year 2024 Results Key Financial Results Revenue: €191.3m (up 64% from FY 2023).
The Manila Times1h
Resolutions from Zealand Pharma's Annual General Meeting 2025
The Annual General Meeting acknowledged the management's report on Zealand Pharma's activities in the past financial year and ...
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
No. 6 / 2025Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, March 25, 2025 ...
STAT15d
Roche partners with Zealand Pharma to push forward obesity drug
Roche partnered with Zealand Pharma to license an experimental weight loss drug for $1.65 billion upfront, expanding its ...
LGBTQ Nation on MSN10mon
The Catholic Church secretly helped develop the drug that made IVF possible
But it turns out the Vatican played a key role in the development a breakthrough drug that made the treatment ... Pius XII ...
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
No. 5 / 2025Zealand Pharma increases its share capital as a result of the exercise of employee warrantsCopenhagen, ...
Roche secures Zealand obesity drug candidate for up to $5.3 billion
Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker seeks to boost its prospects in the booming ...
Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche
Zealand Pharma shares rose sharply after the Danish pharmaceutical company struck a licensing and collaboration deal of up to $5.3 billion with Roche. Shares in Zealand were up 25% at 609 Danish ...